CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CLEARSIDE BIOMEDICAL INC ownership

CLEARSIDE BIOMEDICAL INC's ticker is CLSD and the CUSIP is 185063104. A total of 47 filers reported holding CLEARSIDE BIOMEDICAL INC in Q3 2023. The put-call ratio across all filers is 1.66 and the average weighting 0.0%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CLEARSIDE BIOMEDICAL INC
ValueSharesWeighting
Q3 2023$17,586
-22.3%
20,2160.0%0.00%
Q2 2023$22,642
+7.7%
20,2160.0%0.00%
Q1 2023$21,025
-7.1%
20,2160.0%0.00%
Q4 2022$22,642
-1.6%
20,2160.0%0.00%
Q3 2022$23,000
-23.3%
20,2160.0%0.00%
Q2 2022$30,000
-36.2%
20,2160.0%0.00%
Q1 2022$47,000
-16.1%
20,2160.0%0.00%
Q4 2021$56,000
-54.1%
20,2160.0%0.00%
Q3 2021$122,000
-11.6%
20,216
-28.4%
0.00%
Q2 2021$138,000
+360.0%
28,221
+136.6%
0.00%
Q1 2021$30,000
-58.9%
11,928
-55.1%
0.00%
Q4 2020$73,000
+78.0%
26,5750.0%0.00%
Q3 2020$41,000
-18.0%
26,5750.0%0.00%
Q2 2020$50,000
-30.6%
26,575
-49.0%
0.00%
Q1 2019$72,000
+28.6%
52,1000.0%0.00%
Q4 2018$56,000
-84.9%
52,100
-13.5%
0.00%
Q3 2018$371,000
-42.4%
60,2220.0%0.00%
Q2 2018$644,000
+55.2%
60,222
+56.0%
0.00%
Q1 2018$415,000
+53.1%
38,6000.0%0.00%
Q4 2017$271,000
-19.8%
38,6000.0%0.00%
Q3 2017$338,000
-4.0%
38,6000.0%0.00%
Q2 2017$352,000
+214.3%
38,600
+175.7%
0.00%
Q1 2017$112,000
-11.1%
14,0000.0%0.00%
Q4 2016$126,00014,0000.00%
Other shareholders
CLEARSIDE BIOMEDICAL INC shareholders Q3 2023
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 2,467,500$14,805,0007.67%
ACUTA CAPITAL PARTNERS, LLC 1,316,268$7,898,0002.79%
AJU IB Investment Co., Ltd. 293,555$1,761,0001.14%
RTW INVESTMENTS, LP 4,206,765$25,241,0000.38%
EAM Investors, LLC 247,561$1,485,0000.25%
Carmignac Gestion 2,475,652$14,854,0000.18%
Curi Wealth Management, LLC 25,000$150,0000.07%
CAXTON ASSOCIATES LP 66,569$399,0000.04%
Newman Dignan & Sheerar, Inc. 21,523$129,0000.04%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 316,600$1,900,0000.04%
View complete list of CLEARSIDE BIOMEDICAL INC shareholders